"People's lives are being put at risk for little commissions from the manufacturers. Jammu and Kashmir has become a hub of sub-standard medicines. The office of Drug Controller in the state has become meaningless and irrelevant," SDP president Darakshan Andrabi told reporters here.
"We appeal to the Union Health Minister to take action soon so that precious human lives are saved. The whole matter should be probed by the CBI, as state government is showing little interest in addressing the issue," he said.
"How can we expect any check on the system, as the government has allowed the medical resources of the state to turn into business centres," he alleged.
"The public worry about the spurious drugs being sold in the state without any fear and check seems unheard by the government, which is totally indifferent to this grave issue," he charged.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
